Quinazoline derivatives and pharmaceutical compositions containing them
    68.
    发明授权
    Quinazoline derivatives and pharmaceutical compositions containing them 有权
    喹唑啉衍生物和含有它们的药物组合物

    公开(公告)号:US07019012B2

    公开(公告)日:2006-03-28

    申请号:US10023099

    申请日:2001-12-17

    CPC分类号: C07D405/12 C07D239/94

    摘要: A compound of general formula I wherein: Ra is a benzyl, 1-phenylethyl, or 3-chloro-4-fluorophenyl group; Rb is a dimethylamino, N-methyl-N-ethylamino, diethylamino, N-methyl-N-isopropylamino, N-methyl-N-cyclopropylamino, N-methyl-N-(2-methoxyethyl)amino, N-ethyl-N-(2-methoxyethyl)amino, bis(2-methoxyethyl)amino, morpholino, N-methyl-N-(tetrahydrofuran-3-yl)amino, N-methyl-N-(tetrahydrofuran-2-ylmethyl)amino, N-methyl-N-(tetrahydrofuran-3-ylmethyl)amino, N-methyl-N-(tetrahydropyran-4-yl)amino, or N-methyl-N-(tetrahydropyran-4-ylmethyl)amino group; and Rc is a cyclopropylmethoxy, cyclobutyloxy, cyclopentyloxy, tetrahydrofuran-3-yloxy, tetrahydrofuran-2-ylmethoxy, tetrahydrofuran-3-ylmethoxy, tetrahydropyran-4-yloxy, or tetrahydropyran-4-ylmethoxy group, or a tautomer, stereoisomer, or salt thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases which have valuable pharmacological properties, in particular an inhibitory effect on signal transduction mediated by tyrosine kinases, their use in the treatment of diseases, especially tumoral diseases and diseases of the lungs and airways, and the preparation thereof.

    摘要翻译: 通式I的化合物,其中:R a a是苄基,1-苯乙基或3-氯-4-氟苯基; R b是二甲基氨基,N-甲基-N-乙基氨基,二乙基氨基,N-甲基-N-异丙基氨基,N-甲基-N-环丙基氨基,N-甲基-N-(2-甲氧基乙基) 氨基,N-乙基-N-(2-甲氧基乙基)氨基,双(2-甲氧基乙基)氨基,吗啉代,N-甲基-N-(四氢呋喃-3-基)氨基,N-甲基-N-(四氢呋喃-2 - 甲基)氨基,N-甲基-N-(四氢呋喃-3-基甲基)氨基,N-甲基-N-(四氢吡喃-4-基)氨基或N-甲基-N-(四氢吡喃-4-基甲基)氨基 组; 环烷基甲氧基,环丁氧基,四氢呋喃-3-基氧基,四氢呋喃-2-基甲氧基,四氢呋喃-3-基甲氧基,四氢吡喃-4-基氧基或四氢吡喃-4-基甲氧基, 或其互变异构体,立体异构体或其盐,特别是其具有有价值的药理学性质的无机或有机酸或碱的生理上可接受的盐,特别是对由酪氨酸激酶介导的信号转导的抑制作用,它们在治疗疾病中的用途, 特别是肺和气道的肿瘤疾病和疾病及其制备。